Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound ... Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound ... Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound ... Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 ...

Compared with semaglutide and insulin, tirzepatide was associated with improved glycemic control and weight loss outcomes among patients with type 2 diabetes. Tirzepatide is associated with longer ...

Novo Nordisk shares slump after study comes out in favor of Zepbound A previous version of this report failed to reflect that the scientific name tirzepatide refers to Zepbound. It has been corrected.